Results 21 to 30 of about 15,494 (292)

Barrett's Esophagus

Gastroenterology Clinics of North America, 2008
Barrett's esophagus is an important step in the pathway to esophageal adenocarcinoma. Since most patients with Barrett's esophagus are undiagnosed and patients present with advanced adenocarcinoma de novo, prognosis for this disease remains poor. To identify those people with Barrett's esophagus who are at particular risk many new technologies are ...
Bird-Lieberman, E, Fitzgerald, R
openaire   +3 more sources

BARRETT'S ESOPHAGUS [PDF]

Chest Surgery Clinics of North America, 1994
The development of the columnar-lined lower esophagus, or Barrett's disease, is an acquired condition due to reflux of gastric and duodenal contents. The medical treatment of patients with reflux disease and Barrett's esophagus is currently the same as for patients with reflux without Barrett's disease which may indicate more aggressive antireflux ...
M, Pera, V F, Trastek
openaire   +4 more sources

Prevalence of Barrett's esophagus in individuals without typical symptoms of gastroesophageal reflux disease Prevalência do esôfago de Barrett em indivíduos sem sintomas típicos da doença por refluxo gastroesofágico

Arquivos de Gastroenterologia, 2008
BACKGROUND: Barrett’s esophagus, the major risk factor for esophageal adenocarcinoma, is detected in approximately 10%-14% of individuals submitted to upper endoscopy for the assessment of gastroesophageal reflux disease related symptoms.
Mauro Carneiro de Freitas, Luciana Dias Moretzsohn, Luiz G. V. Coelho   +2 more
doaj   +1 more source

Endoscopic therapy for Barrett′s esophagus

Journal of Digestive Endoscopy, 2012
Barrett’s esophagus (BE) is the precursor lesion to esophageal adenocarcinoma. This cancer has undergone a rapid increase in incidence in Western societies in the last 30 years.
Nicholas J. Shaheen
doaj   +1 more source

Immunoreactivity of cytokeratins 7 and 20 in goblet cells and columnar blue cells in patients with endoscopic evidence of Barrett's esophagus Imunoreatividade das citoqueratinas 7 e 20 nas células caliciformes e células colunares azuis em pacientes com evidência endoscópica de esôfago de Barrett

Arquivos de Gastroenterologia, 2009
CONTEXT: Barrett's esophagus is characterized by the presence of goblet cells. However, when alcian-blue is utilized, another type of cells, called columnar blue cells, is frequently present in the distal esophagus of patients with endoscopic evidence of
João Carlos Cantarelli Jr., Renato Borges Fagundes, Luise Meurer, Marta Pires da Rocha, André Nicola, Cleber Dario Pinto Kruel   +5 more
doaj   +1 more source

Modeling inflammation and oxidative stress in gastrointestinal disease development using novel organotypic culture systems. [PDF]

, 2013
Gastroesophageal reflux disease (GERD), Barrett's esophagus (BE), graft-versus-host disease (GVHD), and inflammatory bowel diseases such as ulcerative colitis and Crohn's disease are common human gastrointestinal diseases that share inflammation as a key
Bortner, James D, Falk, Gary W, Hartman, Kira G, Lynch, John P, Martín, Martín G, Rustgi, Anil K, Yu, Jian   +6 more
core   +2 more sources

O esôfago de Barrett associado à estenose cáustica do esôfago Barrett's esophagus associated to caustic stenosis of the esophagus

Arquivos de Gastroenterologia, 2003
RACIONAL: A estenose esofágica secundária à ingestão de produtos cáusticos é freqüente no Brasil, principalmente como tentativa de suicídio. O esôfago de Barrett surge como conseqüência do refluxo gastroesofágico crônico.
Nelson Adami Andreollo, Luiz Roberto Lopes, Valdir Tercioti Jr., Nelson Ary Brandalise, Luiz Sérgio Leonardi   +4 more
doaj   +1 more source

Clinical significance of VEGF-A, -C and -D expression in esophageal malignancies [PDF]

, 2005
Vascular endothelial growth factors ( VEGF)- A, - C and - D are members of the proangiogenic VEGF family of glycoproteins. VEGF-A is known to be the most important angiogenic factor under physiological and pathological conditions, while VEGF-C and VEGF-D
Ahn MJ, Baatar D, Banks RE, Berse B, Boucher Y, Coia LR, Dirix LY, Du JR, Gu ZP, Guo WZ, Hefler L, Hickey K, Hironaka S, Isaka N, Ishikawa M, Karpanen T, Kato H, Kitadai Y, Kitamura K, Koide N, Koukourakis MI, Kukk E, Kumar H, Lackey VL, Lewis CE, Li Z, Maniwa Y, Millikan KW, Mobius C, Nagata J, Nguyen M, Noguchi T, Nor JE, Ohtsu A, Roberts WG, Rockwell S, Roder JD, Salven P, Shih CH, Spence GM, Suit HD, Theunissen PH, Uchida S, Vogel SB, Wallner G, Weingartner K, Yamamoto Y, Yang B, Yeo KT   +48 more
core   +1 more source

Short segment Barrett's esophagus and distal gastric intestinal metaplasia Esôfago de Barrett de segmento curto e metaplasia intestinal gástrica distal

Arquivos de Gastroenterologia, 2006
BACKGROUND: Short segment Barrett's esophagus is defined by the presence of
Judite Dietz, Sílvia Chaves-e-Silva, Luíse Meurer, Setsuo Sekine, Andréa Ribeiro de Souza, Gilmara Coelho Meine   +5 more
doaj   +1 more source

Sex steroid hormones in relation to Barrett’s esophagus: An analysis of the FINBAR Study [PDF]

, 2017
Previously we observed strong positive associations between circulating concentrations of free testosterone and free dihydrotestosterone (DHT) in relation to Barrett’s esophagus in a US male military population.
Abnet, Christian C, Anderson, Lesley A, carson, Patrick, Cook, M. B., Dawsey, Sanford M, Drahos, Jennifer, Falk, Roni T, Guillemette, Chantal, Hyland, Paula L, Murray, Liam J, Pfeiffer, Ruth, Taylor, Philip R, Wood, Sharon   +12 more
core   +1 more source